Calyxt, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments Measured at Fair Value and Concentrations of Credit Risk (Tables)

Financial Instruments Measured at Fair Value and Concentrations of Credit Risk (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Fair Value Measurements and Financial Statement Presentation

The fair values of the Company’s financial instruments measured at fair value and their respective levels in the fair value hierarchy as of March 31, 2023, and December 31, 2022, were as follows:


	March 31, 2023								March 31, 2023
	Fair Values of Assets								Fair Values of Liabilities
In Thousands	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Other items reported at fair value:
Common stock warrants	$	—	$	—	$	—	$	—	$	—	$	—	$	1,110	$	1,110

Total	$	—	$	—	$	—	$	—	$	—	$	—	$	1,110	$	1,110


	December 31, 2022								December 31, 2022
	Fair Values of Assets								Fair Values of Liabilities
In Thousands	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Other items reported at fair value:
Common stock warrants	$	—	$	—	$	—	$	—	$	—	$	—	$	291	$	291

Total	$	—	$	—	$	—	$	—	$	—	$	—	$	291	$	291

Summary of Fair Value of the Common Warrants

The estimated fair values of the Common Warrants, and the assumptions used for the Black-Scholes option pricing model were as follows:


	As of March 31,			As of December 31,
	2023			2022
Estimated fair value of Common Warrants	$	1.43		$	0.37
Assumptions:
Risk-free interest rate		3.8	%		4.0	%
Expected volatility		90.0	%		85.0	%
Expected term to liquidation (in years)		4.4			4.6